Literature DB >> 17605001

Physiological and pathological properties of alpha-synuclein.

G K Tofaris1, M G Spillantini.   

Abstract

alpha-Synuclein belongs to a small group of natively unfolded proteins that can transiently bind to lipid membranes and acquire a partial alpha-helical conformation. Under certain pathogenic conditions, alpha-synuclein aggregates to form oligomers and insoluble fibrils with increased ss-sheet configuration. Although genetic mutations and multiplications of the gene have been found in familial cases, the mechanism by which this protein aggregates in sporadic cases of Parkinson's disease, dementia with Lewy bodies and multisystem atrophy is not fully understood. Here we review the function of alpha-synuclein and recent insight into the mechanisms by which it aggregates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605001     DOI: 10.1007/s00018-007-7217-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  51 in total

1.  Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.

Authors:  George K Tofaris; Hyoung Tae Kim; Raphael Hourez; Jin-Woo Jung; Kwang Pyo Kim; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-27       Impact factor: 11.205

2.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 3.  Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration.

Authors:  Romana Fato; Christian Bergamini; Serena Leoni; Paola Strocchi; Giorgio Lenaz
Journal:  Neurochem Res       Date:  2008-06-06       Impact factor: 3.996

4.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

Review 5.  Gene-based therapies in Parkinson's disease.

Authors:  Patricia J Allen; Andrew Feigin
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 6.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

7.  Expression and subcellular location of alpha-synuclein during mouse-embryonic development.

Authors:  Shan-chuan Zhong; Xue Luo; Xing-shu Chen; Qi-yan Cai; Jing Liu; Xing-hua Chen; Zhong-xiang Yao
Journal:  Cell Mol Neurobiol       Date:  2009-11-03       Impact factor: 5.046

8.  Localization of synucleins in the mammalian cochlea.

Authors:  O Akil; C M Weber; S N Park; N Ninkina; V Buchman; L R Lustig
Journal:  J Assoc Res Otolaryngol       Date:  2008-07-30

9.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.

Authors:  Irit Rappley; David S Myers; Stephen B Milne; Pavlina T Ivanova; Matthew J Lavoie; H Alex Brown; Dennis J Selkoe
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.